ALACHUA, Fla., (February 15, 2016)—AxoGen, Inc. (NASDAQ: AXGN), a medical technology company focused on the peripheral nerve repair market, will report results for the fourth quarter and full year ended December 31, 2015 on Monday, February 29, 2016 after the market closes.